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Abstract 
Aims 
The aim of the present study was to characterise the familial risk of colon and rectal cancer in 
Iceland. 
Methods 
The standardized incidence ratio (SIR) was used to estimate the risk among relatives of 
colorectal cancer index cases diagnosed in Iceland over a 46 year period (1955-2000). All 
data was retrieved from population based registries (The Icelandic Cancer Registry and a 
Genealogy database from The Genetical Committee of the University of Iceland). 
Results 
The 2,770 colorectal cancer patients had 23,272 first degree relatives. Among first degree 
relatives there was an increased risk of both colon (SIR 1.47, 95% confidence interval [CI] 
1.34-1.62) and rectal cancer (SIR 1.24, 95% CI 1.04-1.47).  An increased risk of colon cancer 
was observed among siblings to colon cancer patients (SIR 2.03, 95% CI 1.76-2.33) whereas 
no such increase was observed for parents and offspring. Furthermore, the risk of rectal 
cancer was only increased among brothers (SIR 2,46 95% CI 1,46-3,89) of rectal cancer 
patients and not among their sisters (SIR 1,0 95% CI 0,40-2,06). The added risk of colon 
cancer among first degree relatives was independent of site of colon cancer in the proband. 
Risk of other cancers outside the colon and rectum was not increased. 
Conclusions 
Family history of colorectal cancer is supported as a risk factor for the disease. Family history 
has different association with colon and rectal cancer giving evidence to different etiologic 
factors for colon and rectal cancer. Siblings of colon cancer patients should be offered 
colonoscopy as screening for colorectal cancer and brothers to rectal cancer patients should be 
subjected to endoscopy screening for rectal cancer. 
 
 
 
 
 
 
 3
Introduction 
The etiology of colorectal cancer (CRC) has been shown to be due to both environmental and 
genetic factors [1]. Evidence for environmental influence comes from migration studies where 
a rise in incidence of colorectal cancer has been reported in populations moving from low risk 
areas to high risk areas [2][3]. Diet is thought to be the main environmental factor. Family 
history is also a known risk factor for colorectal cancer; first degree relatives to patients with 
colorectal cancer have more than a twofold relative risk of colorectal cancer [4][5].  Neither 
dietary studies nor studies on family history have succeeded in explaining the more than 10-
fold variation in colorectal cancer incidence between low risk and high risk areas of the world 
[6]. 
The Icelandic Cancer Project (ICP) was launched in 2001. The aim of the ICP is to create a 
population based clinical genomics database and biobank to study cancer from genetic 
predisposition to clinical outcome [7]. The present study was undertaken within the ICP to 
examine the familial aggregation of colorectal cancer in Iceland. This is important for 
determining familial aggregation at a population-wide level and, more specifically, for 
providing recommendations about screening of colorectal cancer in Iceland. In addition, the 
importance of family history of colorectal cancer as a risk factor for rectal cancer has recently 
been questioned [5][8][9] and it is therefore important to determine separately the colon and 
rectal cancer risk in first degree relatives of colon and rectal cancer patients.   
For the analysis of familial risk of colon and rectal cancer in Iceland, we used two registries 
of high quality, the Icelandic Cancer Registry (ICR) which has information on all cancers 
diagnosed in Iceland since 1955, and a comprehensive genealogy database which permits the 
tracing of all relatives, thereby allowing unbiased analysis of familial aggregation of cancer in 
Iceland. The aim of the study was to use these tools to estimate the magnitude of colorectal 
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cancer risk in relatives of colorectal cancer patients in Iceland and to explore if there is a 
difference of colon or rectal cancer risk in relatives of patients.  
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Materials and Methods 
The Icelandic Cancer Registry (ICR) provided information on all individuals in Iceland 
diagnosed with colorectal cancer during a forty-six year interval (1955--2000); all these 
individuals were included in the study.  The ICR has been in operation since 1954, [10][11] 
covers the entire population of Iceland and determines incidence of cancer by site. The ICR 
receives information from all three pathology and cytology laboratories in Iceland, in addition 
to hospitals, general practitioners, specialists, and individual health workers [12]. 
Approximately 94.5% of diagnoses in the Cancer Registry have histological confirmation 
[12].  The colorectal cancer cases registered in the ICR have close to 100% registration and 
histological confirmation [13][14]. 
The Genetical Committee of the University of Iceland traced the families of the colorectal 
cancer patients to third degree relatives (1st degree relatives include parents, siblings and 
offspring). The committee's data is based on the National Population Registry (NPR), which 
has been in operation since 1952, and provides each permanent resident of Iceland with a 
unique identification number.  The NPR has complete coverage of all inhabitants of Iceland.   
In addition to data from the NPR, the Genetical Committe has traced pedigrees of Icelandic 
individuals back to 1840 through the use of birth-, death-, church- and marriage records.  
Relatives of cancer patients were followed from date of birth or the year 1955, whichever 
came later. They were followed until death in the NPR and to diagnosis of the cancer in 
question in the ICR or the end of the year 2000, whichever came earlier. The population based 
cancer registration and the follow-up of individuals is made possible by the NPR. In the 
period 1961-2000, immigration ranged between 0.07-1.05% (per annual population), 
emigration ranged between 0.17-1.33%, and the net change ranged between 0.02--0.67% 
[13][14][15]. Immigration/emigration was not controlled for. However, given the small 
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percentage of immigration/emigration during the research period, the effects can be 
considered negligible. Calendar year from 1955 up to and including 2000 and patient age 
were used as stratification variables when calculating person-years. Patient age was defined 
by 5-year strata. The risk of cancer was estimated as the ratio between the observed and 
expected number of cases (standardized incidence ratio, SIR). The SIR compares the observed 
number of cases in a cohort with an expected number obtained by applying calendar- and age-
specific standard rates to the cohort age structure [16]. Confidence intervals (CI) and tests for 
trends were calculated assuming a Poisson distribution [16]. Since the confidence intervals 
were always 95%, one interval out of 20 is expected to exclude 1.00 by chance.  The 
confidence intervals were calculated based on the assumption of independence. Since the 
individuals come from the same families, the assumption of independence leads to narrower 
confidence intervals. In order to test the existence of a trend the χ2 method was used [16].  
This study was approved by the National Bioethics Committee and The Privacy and Data 
Protection Authority in Iceland. Statistical analysis was done using the statistical system R 
[17]. 
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Results 
A total of 2,770 individuals (1,376 males; 1,394 females) were diagnosed with colorectal 
cancer in Iceland during the period 1955-2000.  At diagnosis of colon or rectal cancer in the 
probands, 553 patients were under the age of 60 years, 1,655 patients were 60 – 80 years and 
562 patients were over 80 years old. The mean age at diagnosis of colon or rectal cancer in the 
probands was approximately 70 years (SEM 0,24). A total of 2,001 probands had only colon 
cancer, 746 had only rectal cancer, and 23 had both colon and rectal cancer (Table 1). The 
23,272 first degree relatives of colorectal cancer patients generated 526,345 person years at 
risk, of those 552 individuals were diagnosed with colon or rectal cancer compared with the 
expected number of 391.5 giving a 40% increased risk for colorectal cancer which was 
statistically significant (SIR; 1.41 95% CI 1.30-1.53) (Table 2).  This increased risk was due 
to increased risk both for colon (1.47 95% CI 1.34-1.62) and rectal cancer (1.24 95% CI 1.04-
1.47 ) among first degree relatives of CRC patients (Table 2). Second or third degree relatives 
had no increased risk of either colon or rectal cancer. No statistically significant increased risk 
for cancer of the oesophagus, stomach, rectum, liver, pancreas, prostate, brain, thyroid, breast 
(females), cervix, uterus, or ovary was observed for first, second or third degree relatives of 
colorectal cancer patients.  
Among 16,931 first degree relatives of colon cancer patients there was a statistically 
significant increased risk of colon cancer and a slight, non-significant increase of rectal cancer 
(Table 3).  This increased risk of colon and rectal cancer was due to statistically significant 
increased risk of colon and rectal cancer in siblings of colon cancer patients. Parents and 
offspring of colon cancer patients did not have an increased risk of colon or rectal cancer 
(Table 3).  Among 6,506 first degree relatives to rectal cancer patients, 143 patients were 
diagnosed with colon or rectal cancer. Brothers of rectal cancer patients had statistically 
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significant increased risk of both colon and rectal cancer (table 4). Risk of rectal cancer was 
not increased in sisters (table 4); this is the only difference in risk between the genders 
observed for first degree relatives of colorectal cancer patients. Sisters of rectal cancer 
patients had increased risk of colon cancer that was close to statistical significance (Table 4). 
Parents and offspring of rectal cancer patients did not show an increased risk of colon or 
rectal cancer (Table 4). 
The point estimates for the relative risk of colon cancer were higher for relatives of probands 
diagnosed with colon cancer before the age of 60 (Table 5). This increased risk was 
statistically significant in siblings of colon cancer probands but not in parents and offspring 
(Table 5). No relative of probands diagnosed with rectal cancer before the age of 60 had colon 
cancer. First degree relatives of rectal cancer probands diagnosed before the age of 60 did not 
have a significant increase in rectal cancer risk (Table 6). The risk estimates in first degree 
relatives increases as the age of the probands decreases (Table 7) and a trend test with the chi-
square method showed that this trend was statistically significant (p = 0.006). 
The added risk of colon cancer among first degree relatives was independent of site of colon 
cancer in the proband (Table 8).  The results did not change when the relatives of probands 
who had both colon and rectal cancer were included (data not shown).  
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Discussion  
Our study suggests familial aggregation of colorectal cancer in the Icelandic population, with 
a 40% increased risk of colorectal cancer among first degree relatives of colorectal cancer 
patients (SIR: 1.41 95% CI 1.24-1.60)(Table 2). This is in line with previous studies.  The 
increased risk was due to increased risk among siblings of colon cancer patients and in  
brothers of rectal cancer patients. The risk was more than threefold in siblings to colon cancer 
patients who were diagnosed before the age of 60. The risk of parents and offspring of 
colorectal cancer patients did not contribute to this increased risk and, surprisingly, the risk of 
rectal cancer in sisters of rectal cancer patients was not increased.  Family history is a well 
known risk factor for colorectal cancer. The clustering of cancer cases in families alone does 
not, however, permit inference of the potential etiological role of genetic factors.  Excess 
clustering in families could be due to several factors, including common genes, shared 
environment, interaction between genetic and environmental factors, or chance. An inference 
of a genetic component might be justifiable if the clustering showed a pattern consistent with 
Mendelian inheritance and higher risk among relatives of patients diagnosed at an early age 
[18].  
The data used in the present study come from two population-based registries, The Icelandic 
Cancer Registry, and the genealogy registry of The Genetical Committee of the University of 
Iceland. The linkage between the two databases allows unbiased and accurate estimation of 
familial risks of cancer. This is particularly important, since the accuracy of self-reporting of 
family history has been shown to be between 65% and 89% compared to more objective 
sources [19][20][21]. In our material we have been able to differentiate between colon and 
rectal cancer in the probands as exposures.  A limiting factor of the present study is the few 
observed cases of colorectal cancer due to the small population of Iceland (census size 
 10
approximately 160,000 in the year 1995 and 290,000 in the year 2000) [15][22][23]. 
Our study confirms an increased risk of colorectal cancer among first degree relatives of 
colorectal cancer patients but our risk estimates are lower than in most other studies (Table 2), 
mainly because the risk of colon or rectal cancer in our study was not increased in parents and 
offspring of colorectal cancer patients.  
 
Relative risk of familial aggregation of colorectal cancer is about twofold in previous 
epidemiologic registry studies [5][24][25][26]. This increased risk has been found in parents, 
offspring and siblings of colorectal cancer patients, with a stronger association in siblings 
compared to parents and offspring in most studies [5][25][26]. The etiology is thought to be a 
mixture of genetic and environmental factors [1][27][28][29]. Strong association in parents 
and offspring could result from high frequency of a dominant inherited trait, like HNPCC and 
FAP [27]. Higher association in siblings has been explained by a recessive gene action 
[30][31][32][33] or shared environment in the same family during the same period [1].   
 
Low risk for colorectal cancer in parents and offspring in our study could be due to fewer 
mutations in the Icelandic population which are inherited dominantly and cause colorectal 
cancer. A search for families in Iceland that fullfilled the Amsterdam and Bethesda criteria 
suggested that HNPCC might be very rare in Iceland [34][35]. A further support of this 
hypothesis is lend by the fact that there was no observed difference in risk of colon cancer in 
first degree relatives of patients with right compared to left sided colon cancer in the present 
study. (Table 3).  There was no added risk of extracolonic cancers observed in first degree 
relatives of colorectal cancer patients. Since HNPCC families have an increased risk of cancer 
in the stomach, endometrium, ovary, pancreas, and brain, [36][37], these findings further 
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suggest that the occurrence of HNPCC may be very rare in Iceland.  The low incidence of 
dominantly inherited traits of colorectal cancer in Iceland is probably the explanation of the 
weak association with family history found in Iceland. 
In our study the risk of colorectal cancer in first degree relatives of colorectal cancer patients 
increases as the age of the probands decreases (Table 7). This is in accordance with previous 
observations [5][25][28] and supports the idea of genetic disposition of colorectal cancer [18].  
In a recent publication, Wei et al. conclude that some risk factors differ in their association 
with colon and rectal cancer (family history, physical activity, height), arguing for different 
etiologies for colon and rectal cancer. They point out that there is a weaker association 
between family history and rectal cancer than there is between family history and colon 
cancer [8].   
In most studies, the frequency of colorectal cancer is equally distributed among men and 
women whereas the risk of colorectal cancer increases more with age in men than in women 
[38]. Higher risk in men has been explained by a less healthy lifestyle of men [39]. 
The only gender difference in colorectal cancer risk observed in our study is that brothers of 
rectal cancer patients have increased risk of rectal cancer while sisters of rectal cancer patients 
do not (Table 4). This gender difference causes a weaker association of rectal cancer to family 
history compared to colon cancer, potentially explaining the weaker association between 
family history and rectal cancer observed in other studies [8][9].  Gender difference in the risk 
of rectal cancer, as opposed to colon cancer, suggests a different etiology for these two 
cancers. In addition to environmental factors which may affect men more than women, [39] 
X-linked inheritance may also play a role.  
Colonoscopy screening has been recommended in groups with a life time risk of developing 
colorectal cancer which is about 10% or more [40][41].  
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The definition of rectal cancer versus colon cancer is from an anatomic and surgical point of 
view. Our results suggest that a difference may exist in the inheritance of cancer arising in 
different parts of the anatomic-surgical rectum. As the localisation of the transition from 
rectal mucosa to colonic mucosa is presently unknown, this calls for the determination of that 
transition.  
We conclude that family history of colorectal cancer is supported as a risk factor for the 
disease in Iceland and that gender difference in the risk of rectal cancer, as opposed to colon 
cancer, suggests a different etiology for these two cancers. Furthermore we conclude that 
incidence of dominantly inherited traits of colorectal cancer is low in Iceland and that high 
risk among siblings compared with parents and offspring for both colon and rectal cancer 
suggests a recessive gene action. At last we conclude that siblings of colon cancer patients 
should be subjected to a colonoscopy screening program to rule out colorectal cancer and 
brothers to rectal cancer patients should be subjected to an endoscopy screening program to 
rule out rectal cancer. 
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Table 1. Number of colon and rectal cancer patients and their first degree relatives. The 23 
probands with both colon cancer and rectal cancer are included in the total number of colorectal 
cancers but not included in the number of colon and rectal cancers respectively. 
 
 
    Probands  First degree relatives 
   ____________________        _______________________________ 
   All ages <60 years  All Parents and offspring Siblings 
______________________________________________________________________ 
 
Colon and  
rectal cancer 2770  553  23272  15588  7684 
 
Colon cancer 2001  381  16931  11308  5623 
 
Rectal cancer 746  172  6506  4386  2120 
_______________________________________________________________________ 
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Table 2. Colon or rectal cancer risk in first degree relatives of colorectal cancer patients 
 
 
 
 
  Colon and rectal cancer.  Colon cancer.   Rectal cancer. 
 
Obs SIR CI, 95% Obs SIR CI, 95% Obs SIR CI, 95% 
___________________ ____________________      ___________________ 
  
Total 552 1.41 1.30-1.53 421 1.47 1.34-1.62 131 1.24 1.04-1.47 
 
Male 278 1.44 1.28-1.62 208 1.51 1.31-1.73 70 1.27 0.99-1.60 
 
Female 292 1.39 1.23-1.55 231 1.44 1.25-1.65 61 1.21 0.93-1.55 
____________________________________________________________________________ 
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Table 3. Risk of colon or rectal cancer in 16931 first degree relatives of colon cancer patients 
 
 
      Colon     Rectum 
__________________  _________________  
 
Relatives Gender Obs SIR CI, 95%  Obs SIR CI, 95% 
________________________________________________________________________ 
 
All  M+F  327 1.55 1.38-1.73  93 1.19 0.96-1.46 
 
Male  166 1.63 1.39-1.90  44 1.08 0.78-1.45 
 
  Female 161 1.47 1.25-1.72  49 1.31 0.97-1.73 
 
Parents and  
offspring M+F  124 1.12 0.93-1.33  31 0.76 0.51-1.08 
 
Male  62 1.17 0.90-1.50  11 0.52 0.26-0.93 
 
  Female 62 1.07 0.82-1.37  20 1.01 0.62-1.56 
 
Siblings M+F  203 2.03 1.76-2.33  58 1.56 1.19-2.02 
 
Male  104 2.14 1.75-2.59  31 1.58 1.07-2.24 
 
  Female 99 1.93 1.57-2.35  27 1.54 1.01-2.24 
_________________________________________________________________________ 
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Table 4. Relative risk of colon or rectal cancer in 6506 first degree relatives of rectal 
cancer patients. 
 
      Colon     Rectum 
__________________  _________________ 
Relatives Gender Obs SIR CI, 95%  Obs SIR CI, 95% 
________________________________________________________________________ 
 
All  M+F  103 1.22 0.996-1.48  40 1.28 0.92-1.75 
 
Male  52 1.31 0.98-1.72  26 1.63 1.06-2.39 
 
  Female 51 1.14 0.85-1.50  14 0.92 0.50-1.54 
 
Parents and  
offspring M+F  37 0.81 0.57-1.12  15 0.89 0.50-1.47 
 
Male  18 0.83 0.49-1.31  8 0.92 0.40-1.81 
 
  Female 19 0.80 0.48-1.25  7 0.86 0.34-1.77 
 
 
Siblings M+F  62 1.61 1.23-2.06  25 1.75 1.13-2.58 
 
Male  32 1.79 1.22-2.53  18 2.46 1.46-3.89 
 
  Female 30 1.45 0.98-2.07  7 1.00 0.40-2.06 
_________________________________________________________________________ 
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Table 5. Relative risk of colon cancer among first degree relatives of colon cancer 
patients diagnosed before the age of 60. 
 
 
      Colon     
__________________     
Relatives Gender Obs SIR CI, 95% 
__________________________________________ 
 
All  M+F  69 2.16 1.68-2.73 
 
Male  38 2.34 1.66-3.21   
 
  Female 31 1.97 1.34-2.80   
 
Parents and  
offspring M+F  26 1.44 0.94-2.12 
 
Male  12 1.33 0.69-2.32  
 
  Female 14 1.56 0.85-2.62 
 
Siblings M+F  43 3.14 2.27-4.23 
 
Male  26 3.77 2.46-5.52 
 
  Female 17 2.49 1.45-3.99 
_____________________________________________ 
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Table 6. Relative risk of rectal cancer among first degree relatives of rectal cancer 
patients diagnosed before the age of 60. 
 
 
 
 
 
      Rectum 
__________________    
Relatives Gender Obs SIR CI, 95% 
__________________________________________ 
 
All  M+F  9 1.93 0.88-3.66 
 
Male  6 2.17 0.79-4.72 
  
Female 3 1.20 0.24-3.51 
 
Parents and  
offspring M+F  3 1.08 0.22-3.16 
 
Male  2 1.39 0.16-5.02 
   
Female 1 0.75 0.02-9.74 
 
Siblings M+F  6 2.43 0.89-5.29 
 
Male  4 3.01 0.81-7.71 
 
  Female 2 1.75 0.20-6.32 
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Table 7. Risk of colorectal cancer in first degree relatives of colorectal cancer patients 
by age groups of the colorectal cancer patients (< = 62 years, 63-79 years and > = 80 years 
old).  
 
 
 
 
Age at diagnosis Number of   Colon and rectal cancer 
of colorectal cancer first degree   
in index cases  relatives  Obs SIR* CI, 95% 
_______________________________________________________ 
 
< = 62   5742   126 1.64 1.36-1.95 
 
63-79   12179   299 1.44 1.28-1.61 
 
> = 80   5353   127 1.21 1.01-1.44 
______________________________________________________ 
 
Total   23274   552 1.41 1.30-1.53 
______________________________________________________ 
* Trend test with the χ2 method (16). χ2=7.49 and p=0.006 
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Table 8. Relative risk of colon cancer in first degree relatives of colon cancer patients 
by site of colon cancer in the colon cancer patients.   
 
 
 
 
 
Relatives Site  Number of   Obs SIR CI, 95% 
    first degree  
relatives 
_________________________________________________________________ 
 
All  Proximal 7522   159 1.69 1.31-2.18 
 
  Distal  6009   108 1.48 1.11-1.99 
 
Siblings Proximal 2589   98 2.08 1.48-2.93 
 
  Distal  1973   68 2.11 1.39-3.20 
 
Parents and Proximal 4933   61 1.30 0.89-1.90 
 
  Distal  4036   40 0.99 0.64-1.58 
 
___________________________________________________________________ 
 
Proximal: Cecum, appendix, ascending colon, transverse colon and splenic flexure.  
Distal: Descending and sigmoid colon. 
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